Spots Global Cancer Trial Database for Chemotherapy-induced Circadian Rhythm Disruption
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Chemotherapy-induced Circadian Rhythm Disruption
Official Title: Chemotherapy-induced Circadian Rhythm Disruption: Investigation Using Biomarker
Study ID: NCT04364347
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to investigate chemotherapy-induced circadian rhythm disruption through biomarkers, and the relationship between chemotherapy-induced circadian rhythm disruptions and side effects of chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Contact Details
Name: Bong-Jin Hahm, M.D.,Ph.D.
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
